Synovus Financial’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $251K | Buy |
15,005
+849
| +6% | +$14.2K | ﹤0.01% | 824 |
|
2025
Q1 | $218K | Hold |
14,156
| – | – | ﹤0.01% | 840 |
|
2024
Q4 | $312K | Buy |
14,156
+572
| +4% | +$12.6K | ﹤0.01% | 748 |
|
2024
Q3 | $245K | Hold |
13,584
| – | – | ﹤0.01% | 832 |
|
2024
Q2 | $221K | Hold |
13,584
| – | – | ﹤0.01% | 798 |
|
2024
Q1 | $192K | Buy |
13,584
+37
| +0.3% | +$522 | ﹤0.01% | 819 |
|
2023
Q4 | $141K | Sell |
13,547
-1,387
| -9% | -$14.5K | ﹤0.01% | 806 |
|
2023
Q3 | $152K | Hold |
14,934
| – | – | ﹤0.01% | 813 |
|
2023
Q2 | $112K | Hold |
14,934
| – | – | ﹤0.01% | 822 |
|
2023
Q1 | $132K | Hold |
14,934
| – | – | ﹤0.01% | 804 |
|
2022
Q4 | $136K | Sell |
14,934
-190
| -1% | -$1.73K | ﹤0.01% | 833 |
|
2022
Q3 | $122K | Buy |
15,124
+190
| +1% | +$1.53K | ﹤0.01% | 820 |
|
2022
Q2 | $112K | Hold |
14,934
| – | – | ﹤0.01% | 823 |
|
2022
Q1 | $140K | Hold |
14,934
| – | – | ﹤0.01% | 825 |
|
2021
Q4 | $120K | Hold |
14,934
| – | – | ﹤0.01% | 843 |
|
2021
Q3 | $146K | Sell |
14,934
-491
| -3% | -$4.8K | ﹤0.01% | 821 |
|
2021
Q2 | $153K | Buy |
15,425
+18
| +0.1% | +$179 | ﹤0.01% | 813 |
|
2021
Q1 | $177K | Sell |
15,407
-200
| -1% | -$2.3K | ﹤0.01% | 728 |
|
2020
Q4 | $151K | Buy |
15,607
+1,127
| +8% | +$10.9K | ﹤0.01% | 744 |
|
2020
Q3 | $130K | Hold |
14,480
| – | – | ﹤0.01% | 690 |
|
2020
Q2 | $179K | Sell |
14,480
-532
| -4% | -$6.58K | ﹤0.01% | 671 |
|
2020
Q1 | $135K | Sell |
15,012
-141
| -0.9% | -$1.27K | ﹤0.01% | 848 |
|
2019
Q4 | $149K | Sell |
15,153
-6,980
| -32% | -$68.6K | ﹤0.01% | 735 |
|
2019
Q3 | $151K | Sell |
22,133
-583
| -3% | -$3.98K | ﹤0.01% | 702 |
|
2019
Q2 | $209K | Sell |
22,716
-5,865
| -21% | -$54K | ﹤0.01% | 599 |
|
2019
Q1 | $448K | Buy |
28,581
+60
| +0.2% | +$940 | 0.01% | 458 |
|
2018
Q4 | $441K | Sell |
28,521
-1,089
| -4% | -$16.8K | 0.01% | 443 |
|
2018
Q3 | $639K | Buy |
29,610
+1,268
| +4% | +$27.4K | 0.01% | 417 |
|
2018
Q2 | $688K | Buy |
28,342
+440
| +2% | +$10.7K | 0.01% | 385 |
|
2018
Q1 | $475K | Buy |
27,902
+85
| +0.3% | +$1.45K | 0.01% | 435 |
|
2017
Q4 | $530K | Buy |
27,817
+6,029
| +28% | +$115K | 0.01% | 414 |
|
2017
Q3 | $384K | Buy |
21,788
+521
| +2% | +$9.18K | 0.01% | 448 |
|
2017
Q2 | $709K | Buy |
21,267
+30
| +0.1% | +$1K | 0.01% | 353 |
|
2017
Q1 | $680K | Buy |
21,237
+3,100
| +17% | +$99.3K | 0.01% | 316 |
|
2016
Q4 | $656K | Sell |
18,137
-1,109
| -6% | -$40.1K | 0.01% | 308 |
|
2016
Q3 | $885K | Sell |
19,246
-185
| -1% | -$8.51K | 0.02% | 263 |
|
2016
Q2 | $977K | Buy |
19,431
+15,331
| +374% | +$771K | 0.02% | 265 |
|
2016
Q1 | $222K | Sell |
4,100
-100
| -2% | -$5.42K | 0.01% | 459 |
|
2015
Q4 | $277K | Sell |
4,200
-6,382
| -60% | -$421K | 0.01% | 398 |
|
2015
Q3 | $600K | Sell |
10,582
-1,527
| -13% | -$86.6K | 0.02% | 325 |
|
2015
Q2 | $716K | Sell |
12,109
-1,204
| -9% | -$71.2K | 0.02% | 309 |
|
2015
Q1 | $830K | Sell |
13,313
-1,624
| -11% | -$101K | 0.02% | 302 |
|
2014
Q4 | $863K | Buy |
14,937
+1,043
| +8% | +$60.3K | 0.02% | 295 |
|
2014
Q3 | $747K | Buy |
13,894
+1,830
| +15% | +$98.4K | 0.02% | 295 |
|
2014
Q2 | $635K | Sell |
12,064
-525
| -4% | -$27.6K | 0.02% | 293 |
|
2014
Q1 | $665K | Sell |
12,589
-2,151
| -15% | -$114K | 0.02% | 282 |
|
2013
Q4 | $592K | Sell |
14,740
-118
| -0.8% | -$4.74K | 0.02% | 284 |
|
2013
Q3 | $557K | Sell |
14,858
-1,514
| -9% | -$56.8K | 0.02% | 288 |
|
2013
Q2 | $643K | Buy |
+16,372
| New | +$643K | 0.02% | 269 |
|